🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Newly published: Rethinking Trade Treaties and Access to Medicines after COVID-19: A Revised Research Agenda bu.edu/gdp/2024/01/31…

How has COVID-19 changed the political, legal and technological landscape for trade + access to medicines? A new report from Rachel Thrasher Brook K. Baker Veronika Wirtz (@verowirtz.bsky.social) Deborah Gleeson Paul Ogendi, PhD Mike Palmedo + coauthors presents a revised research agenda: gdpcenter.org/3SEGzOQ

Pandemic Treaty negotiations on today at #INB9. Here are some of the things I'm most worried about based on evidence & research on how to stop pandemics -Compliance -Access to technology -Community-based pandemic infrastructure 🧵[thread] of recent papers...

Join me and Yuan Qiong Hu (Médecins Sans Frontières) on 9 April for a discussion of the WHO pandemic treaty negotiations and what they mean for access to pandemic medicines. Register here: us02web.zoom.us/webinar/regist…

Very excited to announce that the call for abstracts for the inaugural conference on Commerce, Economy, Trade & Public Health is now open! cetph2024.com/about

New paper led by Brigitte Tenni: Cambodia's Imminent Graduation from Least Developed Country Status: What Will be the Impact of the TRIPS Agreement on Access to HIV and Hepatitis C Medicines in Cambodia? journals.sagepub.com/doi/10.1177/27… @btenni #PublicHealth

Webinar: Overcoming Intellectual Property Barriers to Equitable Medicines Access for Pandemics 🚨TODAY at 7pm AEST🚨 Register now: us02web.zoom.us/webinar/regist… Deborah Gleeson publichealthaus.bsky.social #WFPHA #GPHW24

Looking forward to this inaugural conference on commerce, economy, trade and #publichealth! The call for abstracts has been extended until 17 June.

If you're doing research on trade and health, commercial determinants of health, alternative economic systems, governance for health, financialisation or other topics linking economic policy and public health, this conference is for you! cetph2024.com/call-for-abstr…

Join us in Melbourne for the inaugural conference on commerce, economy, trade & public health. Keynote speakers include Kelley Lee, Ron Labonte & Sharon Friel among others! Abstracts close soon! Kelley Lee Sharon Friel

Calling for abstracts from researchers working on commercial/political determinants of health, economic/trade policy and public health, global/regional governance & related topics: cetph2024.com/call-for-abstr… Commercial Determinants Research Group at LSHTM APHAtrade PETRA Research Network @globalgapa Political Determinants of Health Collective

Our new paper presents 3 case studies examining the factors that have influenced the prioritisation of access to medicines in trade and intellectual property policymaking in Thailand #publichealth @btenni Dr Bel Townsend onlinelibrary.wiley.com/doi/10.1111/jw…

Our new study on access to medicines and the politics of intellectual property in Thailand, led by @btenni, examines three case studies + highlights imp role of Ministry of Health leadership and civil society Deborah Gleeson ANURegNet Avail here: onlinelibrary.wiley.com/doi/10.1111/jw…

Earlybird registration for the inaugural Commerce, Economy, Trade and Public Health Conference 2024 has been extended until Friday 6 September. Don't miss it! Program and registration: cetph2024.com #PublicHealth #cdoh

Africa desperately needs mpox vaccines. But donations from rich countries won’t fix this or the next health emergency theconversation.com/africa-despera… via The Conversation - Australia + New Zealand @btenni

Our new commentary in IJHPM: Pandemic Agreement Must Include Levers to Redirect Pharmaceutical Industry Behaviour During Pandemics ijhpm.com/article_4638.h… #PublicHealth @btenni James Scheibner Dr Bel Townsend with Di Nicol

I have an exciting PhD scholarship opportunity to share for an interdisciplinary project on 'The Political Economy of the Pharmaceutical Innovation System in the UK and Australia and Access to Medical Products for Pandemics'! More information: latrobe.edu.au/study/scholars…

Everyone’s talking about threats to the PBS, but it’s how quickly generics enter the market that’s actually at stake if Australia decides to negotiate over so-called non-tariff barriers to trade for US pharma companies. Here's my explainer: theconversation.com/trump-has-aust… #publichealth

Last week I spoke with Becca Whitehead from MJA Insight about Trump, trade and access to generics in Australia. insightplus.mja.com.au/2025/14/the-pb… #publichealth